Tag Archives: Compliance

0

You must answer each of the three fiscal compliance questions in this section of the eGC1 Budget & Fiscal Compliance page.

Question F1: Will F&A costs be reimbursed at less than a federally negotiated rate for the UW?

The F&A Cost Rate is determined by the location(s) where the research is performed and is charged as a percentage of total Direct Costs. Rates can be found in GIM 13 Supplement: Table of F&A Rates and Base Types. A Primer on F&A Costs, GIM 13 Facilities and Administrative (F&A) Rates, can provide further detail. Guidelines for determining split rates when projects are conducted at two or more locations are found in GIM 13 Supplement: Activity at Two or More Locations.

See also GCA’s page on Facilities & Administrative Costs.

If you answer Yes:

  • Item F1a will display: Attach GIM 13 waiver in attachments section, or provide documentation of sponsor F&A policy (e.g. RFP, application documents, or website URL)
  • Use the text box to enter your documentation, or upload an attachment on the Attached Documents page.

Note: for RRF applications, the answer to this question must be No.

Question F2: Will administrative or clerical support be included in the budget as direct costs? (see GIM 23)

NIH grants do not allow administrative or clerical personnel costs unless they meet the criteria in GIM 23.

If you answer Yes:

  • Explain how administrative or clerical personnel will be used in the proposed project, following the criteria in GIM 23 Appendix A (Examples of Direct Costs).  This must be appropriately justified in the sponsor application, following sponsor guidelines.

Question F3: Does this application commit funds for cost sharing or matching?

Cost Sharing, Matching or Continuation occurs when an application promises to deliver a support or service for which the research grant does not pay.

  • Cost Sharing may be mandatory (required by sponsor) or committed (a contribution of effort or other costs offered by the Principal Investigator which the sponsor does not require as condition of the award).  Cost sharing occurs when an application commits allowable expenses (i.e., personnel, tuition, equipment or services) for which the research grant will not pay. You must charge these costs to an alternate source (UW or third party). You need to identify all sources and they must agree (via the eGC1 approval process) to commit the necessary funds. For more information, see the GCA Cost Sharing Overview page or GIM 21: Cost Share on Sponsored Programs.
  • Matching funds occur when proposal funding is contingent on a unit’s agreement to commit a matching amount of funding ($) to a project. Matching funds may come in the form of a gift or a grant.
  • Continuation funding takes three forms:
    • (a) it provides funding from a secondary source for ongoing support of a project after the original funding is depleted
    • (b) continuation funds may also be granted if the project is unable to be completed by the original time line and the sponsor has agreed to provide supplemental funding to see the project through to completion
    • (c) continuation funding also occurs when a portion of the original funding commitment is continued and the remaining budget must be found in grant money.

If you answer Yes:

  • Identify whether you are including cost sharing, matching or program continuation.
  • Provide a brief explanation in the text box and attach the completed Addendum form on the Attached Documents page. (On the Addendum, complete all fields including faculty effort, budget number and third party contribution.)
  • Indicate the cost sharing amounts and sources in the Personnel section of the eGC1’s Cost Sharing page.

March 2016 SAGE Maintenance Release

General Updates

A New OAW Compliance Question for Significant Protocol Changes

A new compliance question, AC-1-D, has been added to identify grants that will require a Significant Change at the time of submission. An answer is required if the Animal Use question AC-1 is answered “Yes”.

A few textual enhancements (for existing compliance questions) were made to allow OAW to process the grants more efficiently, and they include:

  1. Removing the facility name and location of the work to be done on the AC-1-A for UW work
  2. Requesting the 3-year approval date range
  3. Updating electronic document submission contact info.

Sub-Object Codes 05-47 and 05-48 Added to Sage Budget for Grandfathered Awards

Effective July 1, 2016, UW’s equipment capitalization threshold will increase from $2,000 to $5,000. This change applies to all competing proposals submitted to sponsors on or after May 1, 2016. The following changes were made in Sage Budget to accommodate this threshold change:

  1. Two new object codes will be added to (05) Supplies and Materials to allow grandfathered awards to continue to use the old threshold for non-capitalized equipment:
    • 05-47 Non-Capitalized Equipment ($2,000-$4,999) – Grandfathered Awards
    • 05-48 Non-Capitalized Equipment – M&E Tax Exempt ($2,000-$4,999) – Grandfathered Awards
  2. These two new object codes will be excluded from F&A calculation when using the following cost bases for budgets associated with grandfathered awards:
    • Exclude 05-47 and 05-48 form Total Direct Costs less Equipment & Tuition (TDC less E&T)
    • Exclude 05-47 and 05-48 from Modified Total Direct Costs (MTDC)
  3. The following object code descriptions will be updated as listed below to reflect the new threshold of $5,000:
    • 05-40 Non-Capitalized Equipment (less than $5,000)
    • 05-41 Non Capitalized Equipment –M&E Tax Exempt ($200 – $4,999)
  4. The following object code descriptions will be updated as listed below to reflect their INACTIVE status upon 4/1/2016:
    • 06-10 Inactive – Computing Equipment ($2,000-$4,999)
    • 06-12 Inactive – Computing Equipment – M&E Tax Exempt ($2,000-$4,999)
    • 06-90 Inactive – Other Equipment (Non-computing) ($2,000-$4,999)
    • 06-92 Inactive – Other Equipment (Non-computing) – M&E Tax Exempt ($2,000-$4,999)

Personnel with an Invalid NetID will not be selectable

With this change, all active staff in the Person Web Service will continue to show in the results on staff search, but those without NETIDs will not be selectable, and users will see a note indicating that the NETID must be established before the person can be selected.  Allowing personnel without NETIDs to be selected as personnel caused errors on the personnel list afterward.

Grant Runner Forms-D Implementation

Grants.Gov will be updating its systems to FORMS-D, for all applications submitted for due dates on or after May 25, 2016. The Grant Runner forms that will be updated to comply with FORMS-D requirements are identified below. There may be some application packages which include both a FORMS-C and a FORMS-D as options, and in this case users will be prompted in SAGE to select the appropriate one based on the due date. Per NIH, FORMS-C application packages will be set to expire after the May 7, 2016 AIDS due date.

Update of PHS 398 Cover Page Supplement to Forms-D

For Grants.Gov FORMS-D, users will notice the following changes applied to the Grant Runner Coverage Page Supplement form:

  • A new “Vertebrate Animals” section, which includes questions on euthanization and use of AVMA guidelines.
  • Removal of the PD/PI section
  • Removal of the Disclosure Permission section
  • The ability to add Program Income information for 10 budget periods (previously 5)
  • Re-ordering of fields to accommodate the new additions and removals

Update of PHS 398 Research Plan to Forms-D

For Grants.Gov FORMS-D, users will notice the following changes applied to the Grant Runner PHS 398 Research Plan form:

  • New “Data Safety Monitoring Plan” attachment
  • New “Authentication of Key Biological and/or Chemical Resources” attachment

Creation of a New PHS Inclusion Enrollment Form for Forms-D

For Grants.Gov FORMS-D, users will notice a new form called “PHS Inclusion Enrollment Report” in Grant Runner. This single form will replace the 2 separate forms in FORMS-C applications (Cumulative Inclusion and Planned Enrollment Report). With the Forms D changes, users will notice some additional fields to identify the type of reporting being done (“Delayed Onset Study?”, “Enrollment Type?”, “Existing Data Set or Resources?”) When “Delayed Onset Study” is marked YES, the remainder of the form will be disabled, per form rules.

Store activity type code for Grant Runner Applications

In order to aid in the analytics of Grant Runner usage, the SAGE system will begin to retrieve and store the Activity Type code from Grants.Gov, as we are retrieving submission status information.

Fixes

Error when Inactivating Advances

An issue that was causing users to receive an error when trying to discard advances has been fixed.

September 2015 SAGE Maintenance Release

EHS-2 Compliance Question Update

The EHS-2 question on the Compliance Questions and Explanations pages of the eGC1 has been updated on all new eGC1s created after the September 2015 release.

Updated logic for the display of the HS-1-B Compliance Question Explanation

The HS-1-B question on the Compliance Explanations page of the eGC1 will now display under the additional condition of a Contract that is utilizing Just-In-Time human subjects approval.

Compliance question HS-1-B was not displaying/hiding in real time, when Project Type = Contract

Conditional questions and instructional text in the Human Subjects section of the Compliance Explanations page of the eGC1 now update in real-time when the eGC1 is for a Contract.

 Prevent multiple RegIDs for the same person from being entered into SAGE

When a user is erroneously assigned multiple RegIDs at the University, it has caused problems with accessing their FIDS information. A change has been made to disallow multiple RegIDs for the same person in the SAGE database.  Upon logging into SAGE, the user will receive an error that is also recorded in the SAGE Suite error log. This error will alert the SAGE team to take the necessary action to resolve the issue with UW IT.

Grant Runner Validation Update on Detailed Budget

A validation was added to the Grant Runner detailed budget form to disallow zero entries in the “other” cost field. This will help mitigate submission errors.

SERA   

Older FAs in SERA have problems opening

An issue that had prevented Funding Actions that predated the creation of the Authorized Action field from being opened in SERA has been fixed.

1
SEC-1. Will any export-controlled items be transported outside the United States in connection with this project?
If any part of the project and/or collaboration takes place outside of the U.S., you will need to determine if your items would be considered export-controlled by U.S. laws and regulations: Export Administration Regulations (EAR) and the International Traffic in Arms Regulations (ITAR).

SEC-2. Will any export-controlled technology be shared with or transferred to foreign persons (including UW employees and students), on or off campus?
If the project or collaboration involves an export-controlled technology AND a foreign person, a Technology Control Plan may be required. Location is not relevant; the transfer of export-controlled technology to a foreign person in the U.S. or in a foreign location is an export.

  • If you answer Yes, please provide a short explanation of what will be shared or transferred.
  • For assistance determining whether your items would be considered export-controlled, use the Catalyst WebQ tool.
  • For additional help and examples, see OSP’s Export Compliance – SEC-2.
SEC-3. Will this project potentially involve restrictions on participation, restrictions on access to research facilities, or restrictions on publication?
Restrictions can be imposed by various means including, but not limited to:

  • Export Controls
  • Security Classification
  • Proprietary Rights

Accepting such restrictions may require a review of the proposed grant or contract by the Faculty Council on Research (FCR) to ensure that the academic benefits to the University, and the communities it serves, will justify the exception. More information is available in UW Executive Order 8.

SEC-4. Will this project potentially involve access to classified national security information?
These projects can take place at the UW or another facility and involve access to classified information or sensitive government facilities, and thus require U.S. persons with a “need-to-know” status to receive appropriate personnel security clearance to perform on such tasks and orders. For more information, see UW’s Industrial Security Program and OSP’s Export Compliance – SEC-4.

 

0

The Environmental Health and Safety compliance questions were revised in March 2013. If you have questions, see the Environmental Health and Safety (EH&S) Web site, send an email message to ehsdept@uw.edu, or call EHS Research and Occupational Safety at 206.221.7770.

You do not need to enter any data if you answer Yes to an EHS question. Do be sure to read the additional information provided.

EHS-1. Will this project involve the use of biohazardous agents which include recombinant or synthetic DNA, human cell lines or tissue, viral vectors, bacteria, viruses, parasites, or other biohazardous agents as defined here? For projects involving human research participants, select yes if 1) the research involves recombinant or synthetic DNA (e.g. human gene transfer, recombinant or synthetic DNA vaccines), or 2) if work with human blood and source material will be performed in a non-clinical UW research laboratory.
 Biological Use Authorization (BUA) from the UW Institutional Biosafety Committee (IBC) is required as defined on the EH&S webpage. Please note that some categories of research require BUA prior to initiation. The BUA application submission deadlines are also posted on this website.
EHS-2. Will this project involve the acquisition, possession, use, transfer, or shipping of Select Agents and Toxins (at any quantity)? Agents include but are not limited to: Botulinum neurotoxins (Botox); Tetrodotoxin; Burkholderia mallei/ pseudomallei; SARS-associated coronavirus; 1918 and Avian influenza virus (highly pathogenic); Bacillus anthracis; Francisella tularensis; Coxiella burnetii; Yersinia pestis; Botulinum neurotoxin producing strains of Clostridium; Conotoxins. See the complete list on the CDC Select Agent Program website.
 EH&S approval of this eGC-1 is required due to federal regulations. EH&S will work with the PI to obtain necessary federal clearances, approvals, and training.Documentation of due diligence is required for any transfer of Select Toxins in any amount. Some Select Agent and Select Toxin research is subject to review by the Dual Use Research of Concern (DURC) Institutional Review Entity (IRE).

See the EH&S website for information about Select Agents and Select Toxins, Select Toxin Due Diligence, and DURC.

EHS-3. Will the proposed project generate mixed radioactive and hazardous chemical waste (i.e., radioactive materials mixed with heavy metals, flammable, reactive, and/or environmentally persistent chemicals)?
 EH&S will follow-up with the Principal Investigator to explore alternatives to avoid mixed radioactive and hazardous chemical waste.
EHS-4. Does the proposed project involve any of these specialized uses of radiation: transuranics, gaseous alpha-emitters, or intentional release of radionuclides to the atmosphere?
 EH&S will follow-up and explore alternatives with the Principal Investigator.
EHS-5. Will your research require the use of highly toxic, highly unstable, highly water reactive, pyrophoric, flammable gas, explosive or materials of similar hazard in quantities in excess of this table?
 EH&S will contact you with planning assistance as fire department requirements may not allow these quantities in your space or may require building modifications.
EHS-6. Does this sponsor require UW Environmental Health and Safety (EH&S) review prior to submission to the sponsor?
 EH&S will contact the PI to initiate review and obtain necessary signatures. For Department of Defense (DOD) Certificates of Environmental Compliance (CEC), please complete the steps listed on the EH&S DOD CEC website.
EHS-7. Will the project involve scientific diving?
 Anyone diving under the University of Washington’s auspices must have current certification as a University of Washington Scientific Diver and adhere to the standards set forth in the UW’s Diving Safety Manual. EH&S will contact you to assist in meeting Diving Safety Program requirements prior to diving.
1

If this is an NIH new or competing renewal application utilizing Just In Time policy, provide as much information as is available at this time. All of the following will need to be provided prior to grant and eGC1 review and sign-off by the IACUC office (for example, after the PI receives a fundable score from Study Section).

Note: Send any documents or questions to the UW IACUC office at oawsend@uw.edu

AC-1: Does this application involve the use of vertebrate animals?
Answer Yes if this application or subaward involves the use of vertebrate animals.

If you answer Yes:

  • Complete questions AC-1-A, B, C and D as described below.
AC-1-A: Does the application involve the use of live vertebrate animals, at any location, by UW faculty, staff or students, or non-UW personnel visiting the UW and working under a UW IACUC protocol?
If you answer Yes, provide the following information for each UW IACUC protocol:

  • IACUC Protocol Number: List all relevant IACUC protocol numbers. If IACUC will be writing a new protocol, use 0000-00.
  • IACUC Approval Date Range (3 years): Provide the 3-year IACUC approval date range for each protocol number listed above.

See also the IACUC web site.

AC-1-B: Does the application involve use of live vertebrate animals at any domestic (US) location other than the UW (e.g. custom antibodies, contracts, subawards or any collaborative work in support of the specific aims of the grant)?
If you answer Yes, please provide the following for each non-UW protocol:

  • Name of Facility: Indicate the facility where the work will take place (for example, “R & R Rabbitry”, “University of Pittsburg”).
  • Facility Location: Indicate the location where the work will take place (for example, “Pittsburg, PA”).
  • Animal Welfare Assurance Number: Indicate the Animal Welfare Assurance Number for each facility listed above (for example, “A3187-01” for the University of Pittsburg).
  • IACUC Protocol Number: List all relevant IACUC protocol numbers. A response of “Pending” or “JIT” is no longer an option.
  • IACUC Approval Date Range (3 years): Provide the most recent IACUC approval date range for each protocol number listed above.

If the PI does not know which protocol(s) will be used, or if IACUC will be writing a new protocol, only then should the protocol number be listed as “0000-00” (zeros) with no dates entered.

Provide a letter from the IACUC office of each of the facilities cited. The letter must confirm the protocol number and approval dates listed above, and it must indicate that the animal work is approved as described in the grant. A confirmation letter is not required from institutions that have inter-institutional agreements with the UW, such as the Fred Hutchinson Cancer Research Center and the Veterans Administration (VA) . However, for those institutions, the protocol(s) cited must be filed with the UW IACUC office. If they are not already on file, please provide them.

See also the NIH’s list of domestic Assurance Numbers.

AC-1-C: Are you citing any foreign sites for performance of live vertebrate animal work?
If you answer Yes, please provide the following for each foreign protocol:

  • Name of Foreign Facility: Indicate the name of the foreign facility where animal work will be conducted (for example, “University of London”).
  • Location: Indicate the location of the facility (for example, “London, United Kingdom”).
  • Animal Welfare Assurance Number: Indicate the Animal Welfare Assurance Number for each facility listed above (for example,  “A5195-01” for the University of London). A response of “Pending” or “JIT” is no longer an option.

Also provide:

  1. A letter from each foreign institution confirming that they have approved the protocol, and the date of approval.
  2. An English language copy of each protocol, for review and approval by the UW IACUC.

See also the NIH’s list of foreign Assurance Numbers.

AC-1-D: Will a Significant Change to any protocol associated with this proposal be required to perform the animal work?
Select Yes if the current protocol does not contain the studies, procedures, or animals that are in the proposal. It is highly advisable to prepare and submit an SC as soon as possible after you receive an indication of the likelihood of funding.

Select No if the protocol already covers all aspects of the proposal.

No further explanation is required.

0

Note: An eGC1 will be held up or denied without appropriate Human Subjects approval, pending approval, or Just In Time designation.

HS-1: Does this application involve the use of human subjects?
Answer Yes if this application or subaward involves the use of human subjects in biomedical, behavioral, minimal risk, or exempt research.If you answer Yes:

  • Answer questions HS-1-A and HS-1-B, if necessary
  • For HS-1, complete the HS Application Type, Number, and Additional Information fields

HS Application Type

Choose the type of Human Subjects protocol from the drop-down menu:

It is the Principal Investigator’s (PI’s) responsibility to find out whether the sponsor for the grant proposal uses the Just-in-Time procedure. Some federal agencies, as well as private, non-profit organizations do; others do not. UW researchers can contact the Office of Sponsored Programs (OSP) if they need help in making this determination.

Number

Enter the IRB protocol number appropriate for each funding application, or enter “pending” if it is pending at the Human Subjects Office.

See also

Additional Information

Add comments as necessary to assist OSP and HSD in locating the appropriate Human Subjects application(s). For example, if the protocol is at another IRB institution, identify it. If it is listed under a different PI, provide the name of the PI.

HS-1-A: Is this application a clinical trial?

A clinical trial is a study designed to assess the safety and/or efficacy of drugs, devices, diagnostics, treatments, or preventive measures in humans. Check Yes if the application includes this type of research.

Pharmaceutical sponsored clinical trials should use the Industry-Sponsored Clinical Trial F&A Cost Rates for this application; Federally sponsored clinical trials should use the federally negotiated F&A Cost Rate for their location. Check No if the application does not fit within this definition (for example, if you are conducting chart review or lab services) and use the full F&A Rate for your location.

HS-1-B: If any of the following statements apply to this proposed work, mark “Yes”, even if the research involves only usual patient care items or the study budget will not be charged.

  • Some of the proposed work will be conducted in a UW Medicine clinical setting. See the CRBB Coverage Analysis Checklist, Section II, Sites of Practice, for a complete list of sites. Studies using Seattle Cancer Care Alliance locations should use the SRAMP access point when submitting to CRBB.
  • The study involves one or more clinical procedures at one of these sites, such as use of a patient examination room, blood draws, imaging, clinical lab tests, administration of a research medication, or procedures.
  • Payment of physician professional fees for clinical services from a UW-affiliated or Northwest Hospital physician is required, separate from the salaried research personnel effort reflected in the budget.

Contact CRBB at crbb@uw.edu or 206-543-7774 for assistance.

This question appears for all eGC1’s in which HS-1 = Yes. If you select “Yes” for HS-1-B, the appropriate alert message will display.

If you have not yet chosen a value for the eGC1 Project Type on the Details page and the HS Application Type on the Explanations page, then the alert that displays reminds you to do so. It reads: “ALERT: For the appropriate detailed instructions, you must select both a Project Type on the Details page and an HS Application Type above.”

If you change the HS Application Type value or the eGC1 Project Type on the Details page, after the initial ALERT has been triggered, a pop-up box will appear stating “Your CRBB review requirements may have changed.” The appropriate alert message based on the new values will then display. For eGC1’s with multiple Human Subjects protocols, SAGE is only able to provide the alert associated with the HS Application Type for the last protocol entered. Please check the table below for the applicable alerts.

Studies eligible for exempt Human Subjects status may involve one or more of the activities described in HS-1-B.  You must complete this question and interface with the Office of Clinical Research Budget and Billing as needed.

UW Medicine sites and entities are numerous and may change from time to time. If you are not sure if a location or physician are part of UW Medicine, please refer to the Coverage Analysis Checklist to verify your answer.

eGC1 Project Type HS Application Type Message displayed when HS-1-B = Yes
Contract New or “Just in Time” ALERT: Before the contract can be executed you must complete either a Coverage Analysis Checklist (or an SRAMP submission if SCCA sites are involved) and provide draft Detailed Budget and Billing Grid forms to CRBB.
Contract Modification or Existing Approval ALERT: If adding or modifying any clinical services, procedures or tests, or if there is a change to the study budget, you must contact CRBB to update the study billing grid and/or the budget.
Grant New or “Just in Time” ALERT: Once funding has been awarded you must complete either a Coverage Analysis Checklist (or an SRAMP submission if SCCA sites are involved) and provide a draft Billing Grid form to CRBB.
Grant Modification or Existing Approval ALERT: If adding or modifying any clinical services, procedures or tests, or if there is a change to the study budget, you must contact CRBB to update the study billing grid and/or the budget.
Contract or Grant Exempt ALERT: Studies with a Human Subjects Exemption status may utilize UW Medicine clinical sites and personnel. Please contact crbb@uw.edu or 206-543-7774 for assistance in determining your next steps.

 

HS-2: Will this research involve the use and/or creation of human embryonic stem cells?
Answer Yes if this application or subaward involves the use and/or creation of human embryonic stem cells in any portion of this research project. See also GIM 36 Human Embryonic Stem Cell Research Policy and Guidelines.
0
NG-2: Does this application have funding from a foreign source or foreign subsidiary entity?
Check Yes if the funding sponsor is a foreign company or organization.

If you answer Yes:

  • Provide the name of the country where the foreign funding sponsor is located.
0

When a preparer answers “Yes” to select compliance questions or a compliance question in combination with other data, the system will add a particular compliance reviewer to the approval flow.

The following table describes the conditions under which a Compliance Reviewer appears and whether the Reviewer is an Approver or a Watcher.

Reviewer Added Condition Approver or Watcher
The selected facility, service center or institute FG-8 =  Yes AND specific Facility or Center selected Approver
Security Reviewer SEC-4 = Yes (potentially involves access to classified national security information) Approver
EHS BioSafety EHS-1 = Yes Watcher
EHS Select Agents EHS-2 = Yes Approver
EHS Waste EHS-3 = Yes Watcher
EHS Radiation EHS-4 = Yes Watcher
EHS Fire Code Compliance EHS-5 = Yes Watcher
EHS Diving EHS-7 = Yes Watcher
Human Subjects HS-1 = Yes AND SFI = Yes for any research personnel Watcher
Animal Subjects AC-1 = Yes AND The application is After-the-Fact (ATF)

OR

The application type is:

  • Transfer from Another Institution
  • Supplement and Extension
Approver

 

Note: For applications where AC-1 = Yes, with an application type other than those listed above, Animal Subjects will do the review just-in-time, when the sponsor notifies the PI that the proposal has a fundable score. At that time, the PI, or other application owner, adds Animal Subjects to the approval flow as an ad hoc watcher. This sends an email notification to the Animal Subjects reviewers and gives them access to the application.

May 2014 SAGE Release

New Features

SAGE eGC1s and Approvals Search Enhancements

Users will see a few new search features available to them, on the eGC1 and Approvals task lists.

  • Users will now be able to jump more directly to a particular eGC1 from their My eGC1s or My Approvals pages, using a new eGC1 search field located on the task lists.
  • Users can now search in My Approvals by personnel name. Search results will include all eGC1s for which they are an approver or watcher, where the chosen person is listed on the PI & Personnel page regardless of role type.
  • The PI Name field has been added back to the My eGC1s Advanced Search tool, to allow users to quickly enter all or part of a PI’s name and initiate a search. This feature was removed in January, when the Personnel Search feature was added, but by user request, both fields will now be available for those that like the speed of being able to quickly find eGC1s by PI name.
  • When a user performs an Advanced Search from the My eGC1s task list, they will be able to export their search results to Excel.

Addition of University District Building to Location List

  • The University District Building has been added to the off campus locations list found on the FG-2 compliance explanations section of the eGC1. It will now be easier for eGC1 Preparers to select that building when projects are eligible for the location designation of “off campus”, and will no longer need to enter the location address.

Suppression of HSD JIT and GIM 19 notifications for ATF and Industry Sponsored Clinical Trail eGC1s

  • Human Subjects Just-In-Time email notifications and GIM 19 deadline email notifications will no longer be sent to contacts for eGC1s that are after-the-fact or industry sponsored clinical trials.

Updated handling when users attempt to remove themselves from an eGC1 or Budget

  • When users remove themselves from an eGC1 or budget, they will now receive a warning, alerting them that their access to that eGC1 or budget may be affected. When users remove their last access to an eGC1 or budget, they will now be redirected back to their task list.